Global Hemostats Market is valued USD 2.15 billion in 2017 is anticipated to grow USD 3.5 billion with the compounded annual growth of 6.1% over the forecast period 2018-2025.
New York 16 Aug 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Hemostats market industry is poised to raise USD 3.5 billion by 2025. The increasing number of hospitals and surgical centres are anticipated for further growth in the hemostats market in upcoming period. However, increase in funding in R&D as well as advancement in technology had leaded to increase the market growth. In other word, we can say hemostats as arterial forceps or hemostatic clamp. Generally, the hemostat is a surgical tool which is used during major surgical procedures in order to control blood loss or halt bleeding during surgery. Hemostats consist of a group of instruments that include pivot, tissue holders, needle holders, and various clamps. Due to the presence of a pool of patients throughout the world, Hemostats market is tremendously growing day by day.
The hemostats market is segmented by product, formulation, application, and region. On the basis of product, the hemostats market is classified into thrombin-based hemostats oxidized regenerated cellulose-based hemostats, combination hemostats, gelatine-based hemostats, and collagen-based haemostats. On the basis of formulation, the hemostats market is categorized into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder haemostats. On the basis of application, the hemostats market is further classified into neurological surgery, cardiovascular surgery, general surgery, orthopaedic surgery, thoracic surgery, gynaecological surgery, urological surgery, and reconstructive surgery. An increase in the number of surgeries, rise in the incidence of various diseases and increase in concern & awareness about health has turned the market growth to its extent in orthopaedic surgeries.
It is expected to increase the market demand in Europe and Asia-Pacific region, while North America is leading the consumer of hemostats market.
To view the summary or to request a sample copy of this report, please click the link mentioned below:
Global Hemostats Market Size study, by Product (Thrombin-Based, Oxidized Regenerated Cellulose-Based, Combination, Gelatin-Based, Collagen-Based), by Formulation (Matrix & Gel, Sheet & Pad, Sponge, Powder) by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others) and by Regional Forecasts 2018-2025
The industry is seeming to be fairly competitive. Some of the leading market players include C. R. Bard, B.Braun, Baxter, Integra Lifesciences, Marine Polymer Technologies, Pfizer, Gelita Medical GmbH, Z-Medica, LLC, Ethicon (Subsidiary of Johnson & Johnson), Teleflex Incorporated, CSL Behring, Cryolife, INC., B Braun Melsungen AG and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- The North American region accounted for the significant market share, more than XX% of the total market in 2016.
- The Asia Pacific region will be the highest growing segment with respect to geographical segmentation, the region is likely to grow by XX% CAGR over the forecast period 2018-2025
Bizwit Research & Consulting LLPhas considered following segments for the study:
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose-Based Hemostats
- Combination Hemostats
- Gelatin-Based Hemostats
- Collagen-Based Hemostats
- Matrix & Gel Hemostats
- Sheet & Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others Surgery
- North America
- Asia Pacific
- Latin America
- Rest of the World